Advertisement
Screener

CLARIVATE PLC (CLVT) Spending and interest coverage

CLARIVATE PLC (CLVT) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
  • Stock-based compensation / revenue · 12 months: Value 2.72%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-03-31.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months2.72%Share-based compensation / revenue. Period ending 2026-03-31.

$66.60M ÷ $2.45B × 100 ≈ 2.72%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)Research and Development Expense
Revenue2.45B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation66.60M USDShare-based Payment Arrangement, Noncash Expense
Operating income122.50M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-03-31(m)$2.45B$66.60M$122.50M(m)(m)2.72%(m)(m)
2025-12-31(m)$2.46B$63.10M$71.50M(m)(m)2.57%(m)(m)
2025-09-30(m)$2.50B$56.40M$-32.20M(m)(m)2.25%(m)(m)
2025-06-30(m)$2.50B$55.30M$-54.50M(m)(m)2.21%(m)(m)
2025-03-31(m)$2.53B$55.70M$-301.40M(m)(m)2.20%(m)(m)
2024-12-31(m)$2.56B$59.90M$-275.60M(m)(m)2.34%(m)(m)
2024-09-30(m)$2.58B$60.80M$-1.00B(m)(m)2.36%(m)(m)
2024-06-30(m)$2.60B$71.30M$-936.00M(m)(m)2.74%(m)(m)
2024-03-31(m)$2.62B$83.20M$-784.30M(m)(m)3.17%(m)(m)
2023-12-31(m)$2.63B$109.00M$-734.70M$293.70M(m)4.15%-2.50×Reported
2023-09-30(m)$2.62B$124.50M$372.00M$295.50M(m)4.75%1.26×Reported
2023-06-30(m)$2.61B$118.30M$-4.09B$295.10M(m)4.53%-13.86×Reported
2023-03-31(m)$2.63B$110.00M$-3.92B$284.40M(m)4.19%-13.77×Reported
2022-12-31(m)$2.66B$93.90M$-3.93B$270.30M(m)3.53%-14.52×Reported
2022-09-30(m)$2.55B$96.73M$-4.21B$304.59M(m)3.80%-13.83×Reported
2022-06-30(m)$2.35B$61.73M$177.42M$298.39M(m)2.62%0.59×Reported
2022-03-31(m)$2.11B$56.73M$27.42M$274.59M(m)2.69%0.10×Reported
2021-12-31(m)$1.88B$33.33M$-86.98M$252.49M(m)1.78%-0.34×Reported
2021-09-30(m)$1.77B$46.02M$-7.36M$180.76M(m)2.60%-0.04×Reported
2021-06-30(m)$1.61B$37.89M$-29.09M$135.81M(m)2.35%-0.21×Reported
2021-03-31(m)$1.44B$29.40M$-3.09M$118.37M(m)2.04%-0.03×Reported
2020-12-31(m)$1.25B$35.42M$2.81M$111.91M(m)2.82%0.03×Reported
2020-09-30(m)$1.05B$31.05M$-43.16M$136.06M(m)2.95%-0.32×Reported
2020-06-30(m)$1.01B$35.10M$5.35M$139.18M(m)3.47%0.04×Reported
2020-03-31(m)$980.91M$64.71M$-45.48M$155.53M(m)6.60%-0.29×Reported
2019-12-31(m)$974.35M$51.38M$-43.09M$157.69M(m)5.27%-0.27×Reported
2019-09-30(m)$964.58M(m)$-33.11M(m)(m)(m)(m)(m)
2019-06-30(m)$964.48M(m)$-87.89M(m)(m)(m)(m)(m)
2019-03-31(m)$965.47M(m)$-85.73M(m)(m)(m)(m)(m)
2018-12-31$13.71M$968.47M$13.71M$-105.71M$130.81M1.42%1.42%-0.81×Reported
2018-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-12-31$17.66M$917.63M$17.66M$-147.03M$138.20M1.92%1.92%-1.06×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
UPWORK, INC (UPWK)United States$1.009B10.23
LEGALZOOM.COM, INC. (LZ)United States$0.970B60.91
Next Technology Holding Inc. (NXTT)$0.836B-0.54
Playtika Holding Corp. (PLTK)$0.833B-5.06
HawkEye 360, Inc. (HAWK)United States$1.567B
EVERTEC, Inc. (EVTC)$1.685B17.01
Yext, Inc. (YEXT)United States$0.641B
DXC Technology Co (DXC)United States$1.728B11.67
OOMA INC (OOMA)United States$0.605B54.69
IBEX Ltd (IBEX)$0.574B8.72